Stock NEOPHARM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications NeoPharm Co., Ltd. Korea S.E.

Equities

End-of-day quote Korea S.E.
Other stock markets
- - Intraday chart for NeoPharm Co., Ltd.
2023 NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2019 NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. A092730 Stock
  4. Stock
  5. News NeoPharm Co., Ltd.
  6. Official Publications